Pharmaceutical

Regeneron to deploy Telesis Bio’s Gibson SOLA at R&D facilities

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D facilities.

May 30, 2025 - 06:00
Regeneron to deploy Telesis Bio’s Gibson SOLA at R&D facilities
Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D facilities.
Read the original article

Tags:

Previous Article

Solid tumours: CAR-T therapies’ Waterloo

Next Article

iTeos to shut down following $2bn GSK-partnered TIGIT asset failure

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: J&J loses a patent battle in India over a crucial tuberculosis drug

STAT+: J&J loses a patent battle in India over a crucia...

Mar 24, 2023

STAT+: The curious case of J&J’s Stelara, the unluckiest drug on Medicare’s list

STAT+: The curious case of J&J’s Stelara, the unluckies...

Sep 2, 2023

MSD’s Gardasil sales slide further due to China constraints

MSD’s Gardasil sales slide further due to China constra...

Apr 26, 2025